List of insiders holdings for FATE THERAPEUTICS INC:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Redmile Group LLC Green Jeremy Director 10% Owner | 2024-03-25 21:30:19 | 0 3,893,674 | 3,893,674 | Form 4 |
| OVP VENTURE PARTNERS VII LP OVP VII ENTREPRENEURS FUND LP 10% Owner | 2013-10-07 14:06:56 | 1,615,274 1,500,289 | 3,115,563 | Form 4 |
| NELSEN ROBERT Director 10% Owner | 2013-10-07 14:00:41 | 0 2,601,635 | 2,601,635 | Form 4 |
| VENROCK ASSOCIATES V LP VENROCK PARTNERS V L P Venrock Entrepreneurs Fund V L.P. Venrock Management V LLC Venrock Partners Management V LLC VEF Management V LLC 10% Owner | 2018-02-13 19:31:09 | 2,473,187 0 | 2,473,187 | Form 13G |
| Polaris Venture Management Co. V L.L.C. Polaris Venture Partners V L.P. Polaris Venture Partners Entrepreneurs' Fund V L.P. Polaris Venture Partners Founders' Fund V L.P. Polaris Venture Partners Special Founders' Fund V L.P. 10% Owner | 2018-12-21 16:34:03 | 1,926,660 0 | 1,926,660 | Form 13D |
| Wolchko J Scott President and CEO | 2024-02-02 16:10:45 | 500,000 0 | 500,000 | Form 4 |
| Valamehr Bahram Chief R&D Officer | 2024-02-02 16:09:29 | 450,000 0 | 450,000 | Form 4 |
| TAHL CINDY General Counsel and Secretary | 2024-02-02 16:10:17 | 425,000 0 | 425,000 | Form 4 |
| Weyer Christian See Remarks | 2015-04-14 15:52:46 | 288,469 0 | 288,469 | Form 4 |
| FATE THERAPEUTICS INC General Counsel and Secretary | 2016-01-12 15:20:44 | 189,109 0 | 189,109 | Form 4 |
| Storgard Chris Chief Medical Officer | 2018-01-17 16:06:10 | 186,000 0 | 186,000 | Form 4 |
| ABBOT STEWART Chief Development Officer | 2018-05-16 17:28:19 | 183,863 0 | 183,863 | Form 4 |
| Chu Yu-Waye Chief Medical Officer | 2023-04-19 16:07:25 | 140,676 0 | 140,676 | Form 4 |
| Plavsic Mark Chief Technical Officer | 2023-01-11 16:07:13 | 123,705 0 | 123,705 | Form 4 |
| Dulac Edward J III Chief Financial Officer | 2024-03-05 16:24:31 | 101,479 0 | 101,479 | Form 4 |
| Flynn Peter D See remarks | 2015-01-07 17:42:41 | 76,505 0 | 76,505 | Form 4 |
| Multani Pratik S Chief Medical Officer | 2015-01-07 17:30:15 | 73,024 0 | 73,024 | Form 4 |
| Shoemaker Daniel D Chief Scientific Officer | 2021-03-09 16:02:06 | 73,020 0 | 73,020 | Form 4 |
| Powl Brian T. Chief Commercial Officer | 2023-07-06 17:19:21 | 41,146 0 | 41,146 | Form 4 |
| EPSTEIN ROBERT S Director | 2023-06-07 16:08:02 | 40,000 0 | 40,000 | Form 4 |
| Lee Michael Stewart Director | 2023-06-08 19:22:26 | 40,000 0 | 40,000 | Form 4 |
| RASTETTER WILLIAM H Director | 2023-06-07 16:13:32 | 40,000 0 | 40,000 | Form 4 |
| MENDLEIN JOHN Director | 2023-06-07 16:11:50 | 40,000 0 | 40,000 | Form 4 |
| Jooss Karin Director | 2023-06-07 16:10:38 | 40,000 0 | 40,000 | Form 4 |
| HERSHBERG ROBERT Director | 2023-06-07 16:09:21 | 40,000 0 | 40,000 | Form 4 |
| COUGHLIN TIMOTHY Director | 2023-06-07 16:06:14 | 40,000 0 | 40,000 | Form 4 |
| Agarwal Shefali Director | 2023-06-07 16:05:41 | 40,000 0 | 40,000 | Form 4 |
| Enyedy Mark J Director | 2017-05-04 11:58:14 | 25,000 0 | 25,000 | Form 4 |
| Nashat Amir Director | 2019-08-02 16:32:23 | 0 11,034 | 11,034 | Form 4 |
| Xu Yuan Director | 2023-08-07 16:01:00 | 9302 0 | 9302 | Form 4 |
| ARCH VENTURE FUND VI LP ARCH VENTURE PARTNERS VI LP ARCH VENTURE PARTNERS VI LLC CRANDELL KEITH BYBEE CLINTON 10% Owner | 2016-12-05 17:28:14 | 0 0 | 0 | Form 13D |